Cited by 2,999Schizophrenia research and treatmentMental Health and PsychiatryDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘‘right stuff’’?

Green, M. F., Kern, R. S., Braff, D. L., Mintz, J.·2000·Schizophrenia Bulletin

DOI 10.1093/oxfordjournals.schbul.a033430

Open this paper in CoChat — free account

Abstract

There has been a surge of interest in the functional consequences of neurocognitive deficits in schizophrenia. The published literature in this area has doubled in the last few years. In this paper, we will attempt to confirm the conclusions from a previous review that certain neurocognitive domains (secondary verbal memory, immediate memory, executive functioning as measured by card sorting, and vigilance) are associated with functional outcome. In addition to surveying the number of replicated findings and tallying box scores of results, we will approach the review of the studies in a more thorough and empirical manner by applying a meta-analysis. Lastly, we will discuss what we see as a key limitation of this literature, specifically, the relatively narrow selection of predictor measures. This limitation has constrained identification of mediating variables that may explain the mechanisms for these relationships.

Integrity signals

Registry

Crossref · 10.1093/oxfordjournals.schbul.a033430

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Book Reviews: Statistical Methods for Meta-Analysis Larry V. Hedges and Ingram Olkin New York: Academic Press, 1985. xxii + 369 pp
Wasserman, S. S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,377
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Self-citation
Vygotsky and the Social Formation of Mind
Kozulin, A., & Wertsch, J. V. (1987) · The American Journal of Psychology · doi:10.2307/1422646 · Cited by 3,339
Untitled work
(1995) · Cited by 2,809
Wisconsin Card Sorting Test manual
Heaton, R. K. (1981) · Medical Entomology and Zoology · Cited by 1,604
Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning
Rao, S. M., Leo, G. J., Ellington, L., Nauertz, T., Bernardin, L., & Unverzagt, F. (1991) · Neurology · doi:10.1212/wnl.41.5.692 · Cited by 890
The Psychology of Vigilance
Loeb, M., Davies, D. R., & Parasuraman, R. (1984) · The American Journal of Psychology · doi:10.2307/1422535 · Cited by 716
National Institute of Mental Health Longitudinal Study of Chronic Schizophrenia: Prognosis and Predictors of Outcome
Breier, A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810270051007 · Cited by 626
Further Evidence for Dementia of the Prefrontal Type in Schizophrenia?
Goldberg, T. E. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800230088014 · Cited by 521
Should schizophrenia be treated as a neurocognitive disorder?
Green, M. F., & Nuechterlein, K. (1999) · Schizophrenia bulletin · doi:10.1093/oxfordjournals.schbul.a033380 · Cited by 447
Self-citation

Show all 62 references

Sorted by citations

Items 601–700 of 1,017

A brief cognitive assessment for use with schizophrenia patients in community clinics
Velligan, D. I., DiCocco, M., Bow-Thomas, C. C., Cadle, C., Glahn, D. C., Miller, A. L., Biggs, M. M., Shores‐Wilson, K., McKenzie, C. A., & Crismon, M. L. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.027 · Cited by 73
Negative symptom improvement during cognitive rehabilitation: Results from a 2-year trial of Cognitive Enhancement Therapy
Eack, S. M., Mesholam‐Gately, R. I., Greenwald, D. P., Hogarty, S. S., & Keshavan, M. S. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.03.020 · Cited by 72
Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia
Wallace, T. L., & Bertrand, D. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.736498 · Cited by 73
Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia
Lindenmayer, J., & Khan, A. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.021 · Cited by 72
Cognitive Remediation: A New Generation of Psychosocial Interventions for People with Schizophrenia
Eack, S. M. (2012) · Social Work · doi:10.1093/sw/sws008 · Cited by 72
Neurocognitive insight and objective cognitive functioning in schizophrenia
Burton, C. Z., Harvey, P. D., Patterson, T. L., & Twamley, E. W. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.021 · Cited by 72
How Frequent is Chronic Multiyear Delusional Activity and Recovery in Schizophrenia: A 20-Year Multi-follow-up
Harrow, M., & Jobe, T. H. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn074 · Cited by 72
Peer-Professional First-Person Account: Schizophrenia From the Inside--Phenomenology and the Integration of Causes and Meanings
Chadwick, P. K. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl034 · Cited by 72
The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis
Johnsen, E., Fathian, F., Kroken, R. A., Steen, V. M., Jørgensen, H. A., Gjestad, R., & Løberg, E. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0769-x · Cited by 72
A Serious Game to Improve Cognitive Functions in Schizophrenia: A Pilot Study
Amado, I., Brénugat-Herné, L., Orriols, É., Desombre, C., Santos, M. D., Prost, Z., Krebs, M., & Piolino, P. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00064 · Cited by 78
Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia
Fisher, M., Loewy, R., Hardy, K., Schlosser, D., & Vinogradov, S. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032511-143134 · Cited by 71
Neuroimaging Heterogeneity in Psychosis: Neurobiological Underpinnings and Opportunities for Prognostic and Therapeutic Innovation
Voineskos, A. N., Jacobs, G. R., & Ameis, S. H. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.09.004 · Cited by 75
Profile of blonanserin for the treatment of schizophrenia
Tenjin, T., Miyamoto, Ninomiya, Kitajima, Ogino, Miyake, & Yamaguchi, K. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s34433 · Cited by 72
Sex differences in cognition among persons with schizophrenia and healthy first-degree relatives
Torniainen‐Holm, M., Suvisaari, J., Partonen, T., Castaneda, A. E., Kuha, A., Perälä, J., Saarni, S. I., Lönnqvist, J. K., & Tuulio‐Henriksson, A. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.11.009 · Cited by 71
Neurocognitive deficits in schizophrenia. Are we making mountains out of molehills?
Moritz, S., Klein, J. P., Desler, T., Lill, H., Gallinat, J., & Schneider, B. C. (2017) · Psychological Medicine · doi:10.1017/s0033291717000939 · Cited by 71
The neuropsychological basis of competence to consent in first-episode schizophrenia: A pilot metacognitive study
Koren, D., Poyurovsky, M., Seidman, L. J., Goldsmith, M., Wenger, S., & Klein, E. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.029 · Cited by 71
Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications
Green, M. F., & BRAFF, D. L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01027-1 · Cited by 71
Self-citation
Neuropsychological functions predict 1‐ and 3‐year outcome in first‐episode psychosis
Carlsson, R., Nyman, H., Ganse, G., & Cullberg, J. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00661.x · Cited by 71
Long-Term Memory Deficits in Schizophrenia: Primary or Secondary Dysfunction?
Holthausen, E. A. E., Wiersma, D., Sitskoorn, M. M., Dingemans, P. M. A. J., Schene, A. H., & van den Bosch, R. J. (2003) · Neuropsychology · doi:10.1037/0894-4105.17.4.539 · Cited by 71
Antipsychotic Drugs for First-Episode Schizophrenia
Salimi, K., Jarskog, L. F., & Lieberman, J. A. (2009) · CNS Drugs · doi:10.2165/11314280-000000000-00000 · Cited by 73
Disentangling the influences of multiple thalamic nuclei on prefrontal cortex and cognitive control
Phillips, J. M., Kambi, N. A., Redinbaugh, M. J., Mohanta, S., & Saalmann, Y. B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.042 · Cited by 75
Cognitive remediation for schizophrenia: current status, biological correlates and predictors of response
Kurtz, M. M. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.71 · Cited by 70
A relationship between neurocognitive impairment and functional impairment in bipolar disorder: A pilot study
Altshuler, L. L., Bearden, C. E., Green, M. F., van Gorp, W. G., & Mintz, J. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2007.01.001 · Cited by 70
Self-citation
Positron Emission Tomography in Schizophrenia: A New Perspective
Patel, N., Vyas, N. S., Puri, B. K., Nijran, K. S., & AL-NAHHAS, A. M. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066076 · Cited by 71
Theory of mind and emotion processing training for patients with schizophrenia: Preliminary findings
Bechi, M., Riccaboni, R., Ali, S., Fresi, F., Buonocore, M., Bosia, M., Cocchi, F., Smeraldi, E., & Cavallaro, R. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.02.004 · Cited by 70
A Systematic and Meta-analytic Review of Neural Correlates of Functional Outcome in Schizophrenia
Wojtalik, J. A., Smith, M. J., Keshavan, M. S., & Eack, S. M. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx008 · Cited by 70
Oral haloperidol or risperidone treatment in rats: Temporal effects on nerve growth factor receptors, cholinergic neurons, and memory performance
Terry, A. V., Gearhart, D. A., Warner, S., Zhang, G., Bartlett, M. G., Middlemore, M.-L., Beck, W. D., Mahadik, S. P., & Waller, J. L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.003 · Cited by 70
Verbal memory deficit in patients with schizophrenia: an important future target for treatment
Toulopoulouand, T., & Murray, R. M. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.1.43 · Cited by 72
Neurocognition in schizophrenia: From prodrome to multi-episode illness
Corigliano, V., Carolis, A. D., Trovini, G., Dehning, J., Pietro, S. D., Curto, M., Donato, N., Pisa, E. D., Girardi, P., & Comparelli, A. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.07.067 · Cited by 80
Perception of socially relevant stimuli in schizophrenia
Bigelow, N. O., Paradiso, S., Adolphs, R., Moser, D. J., Arndt, S. V., Heberlein, A. S., Nopoulos, P., & Andreasen, N. C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.12.856 · Cited by 72
The Istanbul protocol (manual on the effective investigation and documentation of torture and other cruel, inhuman or degrading treatment or punishment): implementation and education in Israel.
Akar, F. A., Arbel, R., Benninga, Z., Dia, M. A., & Steiner‐Birmanns, B. (2014) · PubMed · Cited by 69
Electrodermal predictors of functional outcome and negative symptoms in schizophrenia
Schell, A. M., Dawson, M. E., Rissling, A., Ventura, J., Subotnik, K. L., Gitlin, M. J., & Nuechterlein, K. H. (2005) · Psychophysiology · doi:10.1111/j.1469-8986.2005.00300.x · Cited by 68
A brief cognitive–behavioural social skills training for stabilised outpatients with schizophrenia: A preliminary study
Rus‐Calafell, M., Gutiérrez‐Maldonado, J., Ortega-Bravo, M., Ribas‐Sabaté, J., & Caqueo‐Urízar, A. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.11.014 · Cited by 79
Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis
Piškulić, D., Barbato, M., Liu, L., & Addington, J. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.10.021 · Cited by 68
Sex Differences in Neuropsychological Functioning Among Schizophrenia Patients
Bozikas, V. P., Kosmidis, M. H., Peltekis, A., Γιαννάκου, Μ., Nimatoudis, I., Karavatos, A., Fokas, K., & Garyfallos, G. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903489833 · Cited by 68
Metacognition in psychosis: Comparison of schizophrenia with bipolar disorder
Taş, C., Brown, E. C., Aydemır, Ö., Brüne, M., & Lysaker, P. H. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.06.040 · Cited by 68
Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia
Koshiyama, D., Thomas, M. L., Miyakoshi, M., Joshi, Y. B., Molina, J. L., Tanaka‐Koshiyama, K., Sprock, J., BRAFF, D. L., Swerdlow, N. R., & Light, G. A. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa116 · Cited by 68
Self-citation
Impaired prefrontal cortical dopamine release in schizophrenia during a cognitive task: A [11C]FLB 457 positron emission tomography study
Rao, N., Northoff, G., Tagore, A., Rusjan, P., Kenk, M., Wilson, A., Houle, S., Strafella, A., Remington, G., & Mizrahi, R. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby076 · Cited by 67
The Impact of Aging, Cognition, and Symptoms on Functional Competence in Individuals With Schizophrenia Across the Lifespan
Kalache, S. M., Mulsant, B. H., Davies, S., Liu, A. Y., Voineskos, A. N., Butters, M. A., Miranda, D., Menon, M., Kern, R. S., & Rajji, T. K. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu114 · Cited by 67
Self-citation
Myelin copper and the cuprizone model of schizophrenia
Konradi, C. L. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s129 · Cited by 68
Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy
Lipkovich, I. A., Deberdt, W. G., Csernansky, J. G., Sabbe, B., Keefe, R. S. E., & Kollack‐Walker, S. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-44 · Cited by 70
Cognition dopamine and bioactive lipids in schizophrenia
Yao, J. K. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s153 · Cited by 67
Social Disinterest Attitudes and Group Cognitive-Behavioral Social Skills Training for Functional Disability in Schizophrenia
Granholm, E. L., Ben‐Zeev, D., & Link, P. C. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp072 · Cited by 70
Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia
González‐Blanch, C., Pérez‐Iglesias, R., Pardo‐García, G., Rodríguez-Sánchez, J. M., Martínez‐García, O., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2009) · Psychological Medicine · doi:10.1017/s0033291709991267 · Cited by 71
A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia
Harrow, M., Jobe, T. H., Faull, R. N., & Yang, J. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.06.069 · Cited by 69
Efficacy of social cognition remediation programs targeting facial affect recognition deficits in schizophrenia: A review and consideration of high-risk samples and sex differences
Statucka, M., & Walder, D. J. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2012.12.005 · Cited by 66
A meta-analytic review of the relationship between neurocognition, metacognition and functional outcome in schizophrenia
Davies, G., & Greenwood, K. (2018) · Journal of Mental Health · doi:10.1080/09638237.2018.1521930 · Cited by 66
Psychosocial functioning in first‐episode psychosis and associations with neurocognition, social cognition, psychotic and affective symptoms
Stouten, L. H., Veling, W., Laan, W., van der Helm, M., & van der Gaag, M. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12210 · Cited by 66
Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment
Gilbert, E., Mérette, C., Jomphe, V., Émond, C., Rouleau, N., Bouchard, R.-H., Roy, M., Paccalet, T., & Maziade, M. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0463-7 · Cited by 66
Metacognition as a Mediating Variable Between Neurocognition and Functional Outcome in First Episode Psychosis
Davies, G., Fowler, D. G., & Greenwood, K. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw128 · Cited by 66
What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors
Beck, A. T., Himelstein, R., Bredemeier, K., Silverstein, S. M., & Grant, P. M. (2018) · Psychological Medicine · doi:10.1017/s0033291718000442 · Cited by 70
Learning Potential and the Prediction of Work Skill Acquisition in Schizophrenia
Sergi, M. J. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi007 · Cited by 66
Childhood maltreatment and treatment outcome in psychotic disorders: a systematic review and meta‐analysis
Thomas, S., Höfler, M., Schäfer, I., & Trautmann, S. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13077 · Cited by 72
The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
Uliana, D. L., Lisboa, J. R., Gomes, F. V., & Grace, A. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116298 · Cited by 71
Compensatory cognitive training for people with first-episode schizophrenia: Results from a pilot randomized controlled trial
Mendella, P. D., Burton, C. Z., Tasca, G. A., Roy, P., Louis, L. S., & Twamley, E. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.016 · Cited by 65
‘Theory’ of mind impairment in patients affected by schizophrenia and in their parents
Anselmetti, S., Bechi, M., Bosia, M., Quarticelli, C., Ermoli, E., Smeraldi, E., & Cavallaro, R. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.09.018 · Cited by 71
Predictors of Remediation Success on a Trained Memory Task
Fiszdon, J. M., Cardenas, A. S., BRYSON, G. J., & Bell, M. D. (2005) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000177790.23311.ba · Cited by 65
Dorsolateral prefrontal cortex morphology and short-term outcome in first-episode schizophrenia
Prasad, K. M. R., Sahni, S. D., Rohm, B. R., & Keshavan, M. S. (2005) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2004.05.009 · Cited by 65
Affect recognition deficits in schizophrenia: neural substrates and psychopharmacological implications
Pinkham, A. E., Gur, R. E., & Gur, R. C. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.807 · Cited by 65
Delta Power in Sleep in Relation to Neuropsychological Performance in Healthy Subjects and Schizophrenia Patients
Göder, R., Aldenhoff, J. B., Boigs, M., Braun, S., Koch, J. M., & Fritzer, G. (2006) · Journal of Neuropsychiatry · doi:10.1176/jnp.2006.18.4.529 · Cited by 65
A systematic fMRI investigation of the brain systems subserving different working memory components in schizophrenia
Henseler, I., Falkai, P., & Gruber, O. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06850.x · Cited by 66
Cognition, schizophrénie et effet des antipsychotiques : le point de vue d’un laboratoire de recherche clinique
Stip, É. (2006) · L Encéphale · doi:10.1016/s0013-7006(06)76162-0 · Cited by 65
Effect of multi-session prefrontal transcranial direct current stimulation on cognition in schizophrenia: A systematic review and meta-analysis
Narita, Z. C., Stickley, A., DeVylder, J., Yokoi, Y., Inagawa, T., Yamada, Y., Maruo, K., Koyanagi, A., Oh, H. Y., Sawa, A., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.011 · Cited by 65
Neurocognitive functioning and quality of life among dually diagnosed and non‐substance abusing schizophrenia inpatients
Herman, M. (2004) · International Journal of Mental Health Nursing · doi:10.1111/j.1440-0979.2004.00346.x · Cited by 65
The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients
Good, K. P. (2003) · Schizophrenia Research · doi:10.1016/j.schres.2003.07.001 · Cited by 65
Glutamate as a mediating transmitter for auditory hallucinations in schizophrenia: A 1H MRS study
Hugdahl, K., Craven, A. R., Nygård, M., Løberg, E.-M., Berle, J. Ø., Johnsen, E., Kroken, R., Specht, K., Andreassen, O. A., & Ersland, L. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.11.015 · Cited by 64
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
Haddad, C., Salameh, P., Sacre, H., Clément, J., & Calvet, B. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04552-y · Cited by 64
Abbreviated neuropsychological assessment in schizophrenia: Prediction of different aspects of outcome
Harvey, P. D., Keefe, R. S. E., Patterson, T. L., Heaton, R. K., & Bowie, C. R. (2008) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390802251386 · Cited by 66
Duration of untreated psychosis: Relationship with baseline characteristics and three-year outcome in first-episode psychosis
Chang, W. C., Tang, J. Y. ‐., Hui, C. L. M., Lam, M. M. L., Wong, G. H. Y., Chan, S. K. W., Chiu, C. P. Y., Chung, D. W. S., Law, C. W., Tso, S., et al. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.09.006 · Cited by 64
Duration of untreated psychosis and neuropsychological function in first episode psychosis
Lappin, J., Morgan, K. D., Morgan, C., Dazzan, P., Reichenberg, A., Zanelli, J., Fearon, P., Jones, P. B., Lloyd, T., Tarrant, J., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.05.037 · Cited by 64
The relationship between neurocognition and symptomatology in people with schizophrenia: social cognition as the mediator
Lam, B. Y., Raine, A., & Lee, T. M. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-138 · Cited by 64
Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia
Woon, P. S., Chia, M. Y., Chan, W. Y., & Sim, K. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.01.014 · Cited by 64
Unique Issues in Assessing Work Function Among Individuals with Psychiatric Disabilities
MacDonald‐Wilson, K. L., Rogers, E. S., & Anthony, W. A. (2001) · Journal of Occupational Rehabilitation · doi:10.1023/a:1013078628514 · Cited by 64
The components of executive functioning in a cohort of patients with chronic schizophrenia: a multiple single-case study design.
Chan, R. C. K., Chen, E., Cheung, E. F. C., Chen, R. Y. L., & Cheung, H.-K. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.011 · Cited by 70
Exploring Predictors of Outcome in the Psychosis Prodrome: Implications for Early Identification and Intervention
Niendam, T. A., Jalbrzikowski, M., & Bearden, C. E. (2009) · Neuropsychology Review · doi:10.1007/s11065-009-9108-z · Cited by 64
A Virtual Reality Apartment as a Measure of Medication Management Skills in Patients With Schizophrenia: A Pilot Study
Kurtz, M. M., Baker, E., Pearlson, G. D., & Astur, R. S. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl039 · Cited by 71
Characteristics and predictors of long-term institutionalization in patients with schizophrenia
Uggerby, P., Nielsen, R. E., Correll, C. U., & Nielsen, J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.001 · Cited by 65
Symptoms versus neurocognitive skills as correlates of everyday functioning in severe mental illness
Kurtz, M. M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.1.47 · Cited by 64
The Independent Living Scales as a Measure of Functional Outcome for Schizophrenia
Revheim, N., & Medalia, A. A. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.9.1052 · Cited by 64
Practice-related improvement in information processing with novel antipsychotic treatment
Harvey, P. D., Moriarty, P. J., Serper, M. R., Schnur, E., & Lieber, D. G. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00033-5 · Cited by 64
The Brattleboro Rat Displays a Natural Deficit in Social Discrimination That Is Restored by Clozapine and A Neurotensin Analog
Feifel, D., Mexal, S., Melendez, G., Liu, P. Y. T., Goldenberg, J. R., & Shilling, P. D. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.15 · Cited by 63
The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: A prospective three-year follow-up study
Chang, W. C., Tang, J. Y. ‐., Hui, C. L. M., Wong, G. H. Y., Chan, S. K. W., Lee, E. H. M., & Chen, E. Y. H. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.02.014 · Cited by 63
Time-Dependent Cognitive Deficits Associated with First and Second Generation Antipsychotics: Cholinergic Dysregulation as a Potential Mechanism
Terry, A. V., & Mahadik, S. P. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106047 · Cited by 63
Cannabis users have higher premorbid IQ than other patients with first onset psychosis
Ferraro, L., Russo, M., O’Connor, J. A., Wiffen, B. D. R., Falcone, M. A., Sideli, L., Gardner-Sood, P., Stilo, S. A., Trotta, A., Dazzan, P., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.046 · Cited by 63
Attentional-shaping as a means to improve emotion perception deficits in schizophrenia
Combs, D. R., Tosheva, A., Penn, D. L., Basso, M. R., Wanner, J. L., & Laib, K. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.05.018 · Cited by 63
Amphetamine sensitization in rats as an animal model of schizophrenia.
Peleg-Raibstein, D., Knuesel, I., & Feldon, J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.037 · Cited by 69
Insight and subjective measures of quality of life in chronic schizophrenia
SIU, C. O., Harvey, P. D., Agid, O., Waye, M. M. Y., Brambilla, C., Choi, W.-K., & Remington, G. J. (2015) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2015.05.002 · Cited by 66
A Digit Symbol Coding Task as a Screening Instrument for Cognitive Impairment in First-Episode Psychosis
González‐Blanch, C., Pérez‐Iglesias, R., Rodríguez-Sánchez, J. M., Pardo‐García, G., Martínez‐García, O., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2010) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acq086 · Cited by 64
Relationship between effortful motivation and neurocognition in schizophrenia
Bismark, A. W., Thomas, M. L., Tarasenko, M. A., Shiluk, A. L., Rackelmann, S. Y., Young, J. W., & Light, G. A. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.06.042 · Cited by 63
Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models
Conn, K., Burne, T. H. J., & Kesby, J. P. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00542 · Cited by 66
Evidence that specific executive functions predict symptom variance among schizophrenia patients with a predominantly negative symptom profile
Donohoe, G. J., Corvin, A. P., & Robertson, I. H. (2006) · Cognitive Neuropsychiatry · doi:10.1080/13546800444000155 · Cited by 69
The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia
Weiss, E. M., Bilder, R. M., & Fleischhacker, W. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1053-y · Cited by 63
The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review
Thornton, A. E., Snellenberg, J. X. V., Sepehry, A. A., & Honer, W. G. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881105057002 · Cited by 63
Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions?
Klingberg, S., Wittorf, A., & Wiedemann, G. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-0704-0 · Cited by 63
Neurocognitive functioning and suicidality in schizophrenia spectrum disorders
Barrett, E. A., Sundet, K. S., Simonsen, C., Agartz, I., Lorentzen, S., Mehlum, L. I., Mork, E., Andreassen, O. A., & Melle, I. S. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.06.001 · Cited by 66
Subjective assessments of the quality of life, well‐being and self‐efficacy in patients with schizophrenia
Chino, B., Nemoto, T., Fujii, C., & Mizuno, M. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01995.x · Cited by 62
Visual information processing deficits as biomarkers of vulnerability to schizophrenia: An event-related potential study in schizotypy
Koychev, I. G., El‐Deredy, W., Haenschel, C., & Deakin, J. F. W. (2010) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2010.04.014 · Cited by 62
Relationship of cognitive function in patients with schizophrenia in remission to disability: a cross-sectional study in an Indian sample
Krishnadas, R., Moore, B. P., Nayak, A., & Patel, R. R. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-19 · Cited by 63
Schizophrenia: Treatment Targets Beyond Monoamine Systems
Ibrahim, H. M., & Tamminga, C. A. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105851 · Cited by 63
Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs
Ohi, K., Sumiyoshi, C., Fujino, H., Yasuda, Y., Yamamori, H., Fujimoto, M., Shiino, T., Sumiyoshi, T., & Hashimoto, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123822 · Cited by 62

Authors: Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J.
Affiliations: University of California, Los Angeles (US)
University of California San Diego (US)
Corresponding author: Green, M. F.
ORCID: Kern, R. S.
Mintz, J.
Venue: Schizophrenia Bulletin
Publisher: Oxford University Press (OUP)
Published: 2000-01-01
Volume: 26
Issue: 1
Pages: 119-136
ISSN: 0586-7614 (ISSN-L)
1745-1701
DOI: 10.1093/oxfordjournals.schbul.a033430
OpenAlex: W2150174494
Cited by: 2,999
References: 62
Citations by year: 2026: 49 · 2025: 50 · 2024: 85 · 2023: 77 · 2022: 89 · 2021: 111 · 2020: 120 · 2019: 146 · 2018: 132 · 2017: 143 · 2016: 146 · 2015: 180 · 2014: 146 · 2013: 180 · 2012: 183
FWCI: 31.16
Type: journal article
Language: en
Open access: closed
Locations: Schizophrenia Bulletin (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: schizophrenia, neurocognitive impairment
MeSH terms: Cognition Disorders, Humans, Neuropsychological Tests, Schizophrenia, Schizophrenic Psychology, Social Adjustment, Comorbidity, Cognitive Behavioral Therapy, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘‘right stuff’’?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks